Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle - Implications on decreased myocardial protection in diabetic cardiomyopathy

被引:73
|
作者
Shan, YX
Yang, TL
Mestril, R
Wang, PH
机构
[1] Univ Calif Irvine, Ctr Cardiovasc Hormone Res, Dept Med Biol Chem Physiol & Biophys, Irvine, CA 92697 USA
[2] First Med Univ, Nanfang Hosp, Dept Med, Guangzhou 510515, Peoples R China
[3] Loyola Univ, Dept Physiol, Maywood, IL 60153 USA
关键词
D O I
10.1074/jbc.M304498200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the effects of two heat shock proteins, Hsp10 and Hsp60, on insulin-like growth factor-1 receptor (IGF-1R) signaling in cardiac muscle cells. Neonatal cardiomyocytes were transduced with Hsp10 or Hsp60 via adenoviral vector. Compared with the cells transduced with a control vector, overexpression of Hsp10 or Hsp60 increased the abundance of IGF-1R and IGF-1-stimulated receptor autophosphorylation. Thus, Hsp10 and Hsp60 overexpression increased the number of functioning receptors and amplified activation of IGF-1R signaling. IGF-1 stimulation of MEK, Erk, p90Rsk, and Akt were accordingly augmented. Transducing cardiomyocytes with antisense Hsp60 oligonucleotides reduced Hsp60 expression, decreased the abundance of IGF-1R, attenuated IGF-1R autophosphorylation, and suppressed the pro-survival action of IGF-1 in cardiomyocytes. Using cycloheximide to inhibit protein synthesis did not alter the effect of Hsp60 on IGF-1R signaling, and IGF-1R mRNA levels were not up-regulated by Hsp10 or Hsp60. Additional experiments showed that Hsp10 and Hsp60 suppressed polyubiquitination of IGF-1 receptor. These data indicate that Hsp10 and Hsp60 can modulate IGF-1R signaling through post-translational modification. In animal models of diabetes, diabetic myocardium is associated with decreased abundance of Hsp60, increased ubiquitination of IGF-1R, and lower level of IGF-1R protein. Declined myocardial protection is a major feature of diabetic cardiomyopathy. These data suggest that decreased Hsp60 expression and subsequent decline of IGF-1R signaling may be a fundamental mechanism underlying the development of diabetic cardiomyopathy.
引用
收藏
页码:45492 / 45498
页数:7
相关论文
共 50 条
  • [21] Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma
    Whitson, Bryan A.
    Jacobson, Blake A.
    Frizelle, Sandra
    Patel, Manish R.
    Yee, Douglas
    Maddaus, Michael A.
    Kratzke, Robert A.
    ANNALS OF THORACIC SURGERY, 2006, 82 (03): : 996 - 1002
  • [22] Growth Hormone and Insulin-Like Growth Factor-1
    Nicholls, Adam R.
    Holt, Richard I. G.
    SPORTS ENDOCRINOLOGY, 2016, 47 : 101 - 114
  • [23] Roads to survival - Insulin-like growth factor-1 signaling pathways in cardiac muscle
    Wang, PH
    CIRCULATION RESEARCH, 2001, 88 (06) : 552 - 554
  • [24] Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes
    Fabbi, Patrizia
    Spallarossa, Paolo
    Garibaldi, Silvano
    Barisione, Chiara
    Mura, Marzia
    Altieri, Paola
    Rebesco, Barbara
    Monti, Maria Gaia
    Canepa, Marco
    Ghigliotti, Giorgio
    Brunelli, Claudio
    Ameri, Pietro
    PLOS ONE, 2015, 10 (05):
  • [25] Insulin-like growth factor-1 receptor expression in the placentae of diabetic and normal pregnancies
    Hayati, Abdul Rahman
    Cheah, Fook Choe
    Tan, Ay Eeng
    Tan, Geok Chin
    EARLY HUMAN DEVELOPMENT, 2007, 83 (01) : 41 - 46
  • [26] Functional insulin-like growth factor-1/insulin-like growth factor-1 receptor-mediated circuit in human and murine thymic epithelial cells
    Coelho, VDM
    Villa-Verde, DMS
    Farias-De-Oliveira, DA
    de Brito, JM
    Dardenne, M
    Savino, W
    NEUROENDOCRINOLOGY, 2002, 75 (02) : 139 - 150
  • [27] Regulation of insulin-like growth factor-1 receptor expression by Hsp90 and co-chaperones
    Yanagita, Toshihiko
    Nemoto, Takayuki
    Yoshikawa, Norie
    Satoh, Shinya
    Maruta, Toyoaki
    Murakami, Manabu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 : 98P - 98P
  • [28] Myostatin, the cardiac chalone of insulin-like growth factor-1
    Gaussin, V
    Depre, C
    CARDIOVASCULAR RESEARCH, 2005, 68 (03) : 347 - 349
  • [29] Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
    van der Veeken, J.
    Oliveira, S.
    Schiffelers, R. M.
    Storm, G.
    Henegouwen, P. M. P. van Bergen En
    Roovers, R. C.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 748 - 760
  • [30] Serum levels of insulin-like growth factor-1 and insulin-like growth factor-1 binding proteins after radical prostatectomy
    Bubley, GJ
    Balk, SP
    Regan, MM
    Duggan, S
    Morrissey, ME
    Dewolf, WC
    Salgami, E
    Mantzoros, C
    JOURNAL OF UROLOGY, 2002, 168 (05): : 2249 - 2252